Brian McKelligon

This profile gathers the share dealings of Brian McKelligon in Akoya Biosciences, Inc., where the filings describe the role as chief executive. We count 43 filings; the first trade dates from 23 March 2022 and the latest from 8 July 2025.

Sales make up the whole of the open-market record (14 sales, €461k). The rest of the record consists of 14 share grants and 12 option exercises.

The record was last updated on 10 July 2025 with a transaction in Akoya Biosciences, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.